课题基金 / 基金详情

项目摘要

项目成果

Theodore S Jardetzky的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human cytomegalovirus (HCMV) is member of the herpesvirus family that is widely distributed in the human population and responsible for significant health problems, particularly in immune-compromised individuals and in newborns exposed to the virus during pregnancy or birth. Understanding the immune response to HCMV infection, and in particular the major targets of the neutralizing antibody response, is of great interest as efforts to develop an effective vaccine are of high priority. Recent studies have shown that one of the most potent targets of the neutralizing antibody response is an assembly of 5 HCMV glycoproteins, gH, gL, UL128, UL130 and UL131, into a `pentameric' complex, which is responsible for broadening the infectivity of the virus to endothelial, epithelial and myeloid cells. The gH and gL proteins are part of the core herpesvirus membrane fusion and entry machinery, while the UL proteins represent virus-specific adaptors that modulate cell tropism. Low resolution electron microscopy studies of HCMV gHgL, pentamer and antibody complexes have been reported, providing insight into the overall shape of the pentamer and the locations of neutralizing antibody epitopes. However, no high resolution structures have been determined, limiting our insights into the overall folding and architecture of the gHgL pentamer as well as the relationship between neutralizing antibody epitopes and neutralization potency. Here we will determine the structures of HCMV pentamer in complex with representative neutralizing antibodies. In addition, we will map key gHgL and UL protein residues involved in pentamer assembly, antibody binding and gHgL functions, using cell surface library display approaches. Results generated from this proposal will deepen our understanding of the HCMV entry machinery, facilitate the identification of HCMV entry receptors, and provide key fundamental knowledge for the development of vaccine antigens and small molecule inhibitors to prevent HCMV infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Discovery and engineering of novel anti-IgE disruptive inhibitors
  • 批准号:
    10353982
  • 项目类别:
  • 资助金额:
    $23.61万
  • 财政年份:
    2021
  • 负责人:
    Theodore S Jardetzky
  • 依托单位:
Discovery and engineering of novel anti-IgE disruptive inhibitors
  • 批准号:
    10495213
  • 项目类别:
  • 资助金额:
    $19.68万
  • 财政年份:
    2021
  • 负责人:
    Theodore S Jardetzky
  • 依托单位:
Human Cytomegalovirus Entry into Cells Mediated by Pentamer and Trimer Complexes
  • 批准号:
    10468251
  • 项目类别:
  • 资助金额:
    $75.42万
  • 财政年份:
    2020
  • 负责人:
    Theodore S Jardetzky
  • 依托单位:
Human Cytomegalovirus Entry into Cells Mediated by Pentamer and Trimer Complexes
  • 批准号:
    10687819
  • 项目类别:
  • 资助金额:
    $73.27万
  • 财政年份:
    2020
  • 负责人:
    Theodore S Jardetzky
  • 依托单位:
海外基金